Home iFast Diagnostics

iFast Diagnostics

In operation
-
Antibacterial Drug Susceptibility Testing Platform
Basic
Enterprise Profile
LinkedIn

Basic Information

iFast Diagnostics is an antimicrobial susceptibility testing platform that is developing a system to extract bacteria from blood and urine samples, followed by analyzing the effects of various antibiotics on pathogens using multi-frequency impedance measurements to help determine the optimal treatment.
iFast Diagnostics
England,United Kingdom
15~50 people
January 01, 2022
--

Enterprise Profile

Industrial Sector
Medical Device R&D and Design # Diagnostic Manufacturing
Technology
Microfluidics Microbial/Viral Technology Antibacterial/Antiviral Technology
Concept
Laboratory Diagnosis
Application Scenarios
Medical Devices Medical Device Consumables